Patent 7939557 was granted and assigned to Nova Southeastern University on May, 2011 by the United States Patent and Trademark Office.
The present application describes isoindoles and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful inhibitors of VEGFR.